                         SEQUENCE LISTING

<110>  Children's Medical Center Corporation
       Schepens Eye Research Institute
       VA Boston Healthcare System
 
<120>  ABCB5(+) STEM CELLS FOR TREATING OCULAR DISEASE

<130>  C0875.70066WO00

<140>  TBD
<141>  2014-02-19

<150>  US 61/766,424
<151>  2013-02-19

<160>  20    

<170>  PatentIn version 3.5

<210>  1
<211>  36
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  1
gttgagggga gcagccagag caaggtgaga aaggtg                                 36


<210>  2
<211>  42
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  2
ttaagggtta ttgaatatga tcggaattgg gctgcaggaa tt                          42


<210>  3
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  3
tggggcagga cagcaagggg gaggat                                            26


<210>  4
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  4
ctggtccctc tcctgtgatc tacacaggcc                                        30


<210>  5
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  5
ggaagacaat agcaggcatg ctggg                                             25


<210>  6
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  6
ggctggggca actgaaaagt agcat                                             25


<210>  7
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  7
tttcagcttc agtttatcac aatgtgggtt                                        30


<210>  8
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  8
acttggtgcg gtgactctga attttgc                                           27


<210>  9
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  9
tagcaacatt tctggcattt taggctg                                           27


<210>  10
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  10
ggctggggca actgaaaagt agcat                                             25


<210>  11
<211>  29
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  11
gcaaatgtgt actctgcgct tatttaatg                                         29


<210>  12
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  12
tggtgcagac tacagacgtc agtgg                                             25


<210>  13
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  13
gtgtctgggt ttcatccatc                                                   20


<210>  14
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  14
aatgcggcat cttcaacctc                                                   20


<210>  15
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  15
cagcgctctg ccgcctat                                                     18


<210>  16
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  16
catgaccaac acagatcaaa catcc                                             25


<210>  17
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  17
gaagccgagg gcgattactg                                                   20


<210>  18
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  18
gtgcttgtga tttggagtct gtcac                                             25


<210>  19
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  19
tcctagcacc atgaagatc                                                    19


<210>  20
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  20
aaacgcagct cagtaacag                                                    19